Академический Документы
Профессиональный Документы
Культура Документы
A 56 years old male presented with right upper and lower limb weakness since 4 days before admitted to hospital,
. Weakness are seen suddenly during activity (lifting farming items), and fall. Conscious after attack. The upper and lower limb weakness are equal. Now patient are unable to lift anything and have to be hold by family to walk. He also have difficulty in eating and drinking.
This complain are accompanied with wry mouth and patient cannot speak. Patient cannot understand conversation and cannot say any words. No complain of headache, vomiting, decreased consciousness, and seizures. No complain in sensing, miction and defecation
Past Illness History Known hypertensive since 3 years ago. No regular checkup to doctor. No previous history of stroke. No history of diabetes. Family History of Illness No family history of hypertension, diabetes, heart disease and stroke. Socioeconomic Background Patient is a farmer, smoke 12 stick of cigarette a day since 30 years ago.
General General Appearance: Moderately Ill Level of Consciousness: compos mentis cooperative Pulse Blood Pressure Temperature : 72 x/menit : 180/120 mmHg : 36,7oC Respiratory Rate : 20 x/menit
GCS 15 : E4 M6 Aphasia
Meningeal SIgn Neck stiffness: (-) Brudzinsky I : (-) Brudzinsky II : (-) Kernig Sign : (-)
N. I N. II N. III, IV, VI
N. V N. VII
N VIII
: Difficult to evaluate : Difficult to evaluate : Light reflex +/+ Doll eye movement : difficult to evaluate : Right Nasolabial plica flatter than the left side, Eyelashes Reflex +/+ : difficult to evaluate
N IX NX N XI N XII
: Vomitting Reflex +, capable to swallow : Pharinx arch symmetric, Uvula on the midline : difficult to evaluate : difficult to evaluate
Lower Limb Right Movement Limited Strength Tonus Trophy Fall test 0/0/0 eutonus eutrophy
Reflex
Biceps Triceps
Right
+++ +++
Left
++ ++
APR
KPR
+++
+++
++
++
Reflex
Hoffman-Tromer Balbinsky
Right
+
Left
-
Chaddoks
Oppenheim Gordon
Schaeffer
Hemoglobin Leukocyte
: 14.7gr/dl : 10,500/mm3
Hematocryte
Thrombocyte Sodium Potassium Chloride Urea Creatinine
: 42%
: 140 000/mm3 : 148mmol/L : 3.5mmol/L : 104mmol/L : 60mg/dl : 1.4mg/dl
Other Examination
Blood : PT, APTT, total Cholesterol, uric acid, albumin, globulin, SGOT,SGPT, HDL, LDL, and Trygliceride. Chest X-Ray Non-contrast Brain CT scan Echocardiography
Clinical Diagnosis
Right Hemiparesis+Right NVII and NXII Paresis central type +Global aphasia
Topic Diagnosis Right brain hemisphere, Subcortical Etiology Cardioemboli Secondary Diagnosis Emergency Hypertension, Atrial Fibrillation Normoventricular Response
Oxygen 2L/minute
IVFD RL 12hour/kolf
Medicinal Therapy Piracetam 4x3gr (IV) Bisoporolol 1x2.5mg (Oral) Aspilet 2x 80mg Herbesser Drip 50mg in 50cc Ringer lactate via syringe pump 50cc/hour
Medicinal Therapy
Dietary control Physical Therapy Family education and prevention on hypertension and stroke
1. History
Sudden weakness, conscious after attack, equal upper and lower limb weakness (hemiparesis), are the characteristic stroke. It is said subcortical because when a patient have equal upper and lower limb weakness, it shown that the disturbance are in brain area where all motor tract are bundled up together of subcortical cerebral function disturbance in that happen in non hemorrhagic
Wry mouth are caused by paresis of facial nerve and in this patient are found the central type paresis.
This condition is called arteroscelrosis these fatty deposits can cause two types of obstruction:
a) Cerebral thrombosis refers to a thrombus (blood clot) that develops at the clogged part of the vessel. b) Cerebral embolism refers generally to a blood clot that forms at another location in the circulatory system, usually the heart and large arteries of the upper chest and neck. A portion of the blood clot breaks loose, enters the bloodstream and travels through the brain's blood vessels until it reaches vessels too small to let it pass.
A second important cause of embolism is an irregular heartbeat, known as atrial fibrillation. It creates conditions where clots can form in the heart, dislodge and travel to
the brain.
2. Physical examination
General physical examination reveals that the patient are in emergency hypertension state with
Emergency hypertension are blood pressure elevation with target organ damage. 12x/minute pulsus deficit are also found and this show cardiac insufficiency and shown as inability
Flatter right nasolabial plica are caused by right facial nerve paresis. In motor function test, limited movement and right upper and lower limb strength are 000 interpret as inability to move even the fingers of hand and feet. In Fall Test, Right side lateralisation are found and this shows the weakness in right side limbs.
Chest
X-Ray EKG
and
are heart
Echocardiogram could visualize every heart valve or space and could evaluate heart contraction abnormality
4. Therapy
For Specific therapy, patients are given Piracetam 4x3gr (IV), Bisoporolol 1x2.5mg (Oral), Aspilet 2x 80mg and Herbesser Drip
Recanalization
strategies,
including
IV
recombinant
activator approaches, revascularization injury occurs.
tissue-type
(rt-PA) so and to that attempt
plasminogen
intra-arterial establish in the cells
the
time
window
for
revascularization
techniques; however, at the present time, no neuroprotective agents are available and approved for use in ischemic stroke.
4. Therapy
In Supportive therapy, patients head are elevated 30 degree to prevent high pressure blood flow to further damage the brain. Oxygen 2L/minute, IVFD RL 12hour/kolf,
For Specific therapy, patients are given Piracetam 4x3gr (IV), Bisoporolol 1x2.5mg (Oral), Aspilet 2x 80mg and Herbesser Drip 50mg in 50cc Ringer lactate via syringe pump 50cc/hour.
The central goal of therapy in acute ischemic stroke is to preserve the area of oligemia in the ischemic penumbra. The area of oligemia can be preserved by limiting the severity of ischemic injury (ie, neuronal protection) or by reducing the duration of ischemia (ie, restoring blood flow to the compromised area).
strategies, tissue-type
including
IV
(rt-PA)
and
attempt so that
Neuroprotective strategies are intended to preserve the penumbral tissues and to extend the time window for revascularization techniques; however, at the present time, no neuroprotective agents are available and approved for use in ischemic stroke.